XOOMAR

BRISTOL MYERS SQUIBB CO (BMY)

Every FINRA and SEC series the site collects for BRISTOL MYERS SQUIBB CO: short interest with days to cover, daily short sale volume, fails to deliver and Form 4 insider trades. Listed on NYSE, classified by the SEC as pharmaceutical preparations.

Download CSV

45.9M

Short interest

settlement 2026-08-14

3.5

Days to cover

-12.4% vs prior

51.8%

Short share of volume

2026-09-11

301

Fails to deliver

settlement 2026-08-13

-$437K

Insider flow, 90 days

0 buys, 2 sells

As of 2026-09-11.

Short interest

FINRA, twice a month; the last 12 months shown, all 48 settlements in the JSON

As of 14 August 2026, short interest in BMY is 45,852,662 shares, up 917,300 shares over the last month. Over the last 48 readings it ranged from 20,033,587 shares (30 September 2024) to 52,336,079 shares (31 July 2026). At the reported average volume of 13.2M shares a day that is 3.5 days to cover.

Embed this chartfree, with the attribution line it carries
<iframe src="https://xoomar.com/embed/stocks/bmy" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
PreviewDark previewAdd ?theme=dark to the src for a dark chart.
SettlementShares shortChangeAvg daily volumeDays to cover
2026-08-1445,852,662-12.4%13,183,2813.48
2026-07-3152,336,079+16.5%11,294,1214.63
2026-07-1544,935,362+10.9%10,603,4784.24
2026-06-3040,531,289+2.4%16,383,2352.47
2026-06-1539,595,308+2.8%11,894,7363.33
2026-05-2938,507,952+4.9%11,144,3613.46
2026-05-1536,716,099+17.2%10,381,7003.54
2026-04-3031,330,595-3.3%9,871,5493.17
2026-04-1532,393,759+2.8%9,465,5893.42
2026-03-3131,501,585+5.5%15,833,1951.99
2026-03-1329,852,257-10.7%11,789,1042.53
2026-02-2733,420,961+5.5%13,016,8342.57
2026-02-1331,674,440+6.0%14,615,1572.17
2026-01-3029,894,882-19.1%12,741,0672.35
2026-01-1536,975,176+1.1%12,869,1772.87
2025-12-3136,577,723+3.2%16,091,8112.27
2025-12-1535,431,255+4.5%16,391,2352.16
2025-11-2833,891,065+7.0%14,281,2062.37
2025-11-1431,685,786-1.2%14,120,5232.24
2025-10-3132,070,775+5.6%17,797,7301.80
2025-10-1530,358,285+15.2%17,889,6111.70
2025-09-3026,343,569-10.6%19,180,8801.37
2025-09-1529,470,983-5.5%9,460,2983.12
2025-08-2931,193,823+5.1%9,732,3833.21

Daily short volume

FINRA Reg SHO, last 60 sessions. JSON

As of 11 September 2026, the short share of BMY volume is 51.8%, down 2.2 points over the last five sessions. Over the last 52 readings it ranged from 31.0% (12 August 2026) to 68.8% (14 July 2026). The latest reading is in line with the 30-session average of 50.4%, on 2.2M shares reported.

DateShort volumeTotal volumeShort shareExempt
2026-09-111.2M2.2M51.8%1,688
2026-09-101.1M2.1M54.0%3,950
2026-09-09997K1.9M52.5%3,624
2026-09-081.7M2.7M60.5%1,183
2026-09-04955K1.6M58.0%1,058
2026-09-03988K1.8M54.0%9,130
2026-09-021.1M2.0M55.9%3,410
2026-09-011.1M2.2M49.8%3,679
2026-08-311.1M2.0M56.5%1,996
2026-08-28928K1.7M55.2%1,434
2026-08-27813K1.6M50.6%0
2026-08-261.3M2.0M64.6%7,401
2026-08-251.4M2.3M61.3%20,575
2026-08-241.0M1.9M54.2%2,160
2026-08-211.0M2.1M49.2%3,486
2026-08-201.1M3.0M35.4%2,257
2026-08-192.0M4.0M51.2%7,420
2026-08-181.3M2.8M48.1%5,148
2026-08-171.0M2.2M47.7%621
2026-08-141.2M2.4M51.4%3,308
2026-08-132.2M4.0M53.7%5,499
2026-08-121.0M3.3M31.0%3,866
2026-08-111.7M3.0M56.5%9,253
2026-08-101.4M2.8M47.5%556
2026-08-071.1M2.2M48.7%1,334
2026-08-061.3M3.0M44.5%2,837
2026-08-052.2M4.6M48.3%9,197
2026-08-042.9M8.8M33.3%20,468
2026-08-034.5M11.9M37.9%44,204
2026-07-312.2M4.4M49.0%4,778

Fails to deliver

SEC, by settlement date. JSON

As of 13 August 2026, the fails-to-deliver balance in BMY is 301 shares, up 271 shares over the last settlement date. Over the last 52 readings it ranged from 15 shares (5 January 2026) to 393,782 shares (17 December 2025). The latest reading sits at the bottom of that range.

SettlementShares failedPriceValue
2026-08-13301$63.70$19K
2026-08-0330$65.31$2K
2026-07-3162,638$64.86$4.1M
2026-07-29175$63.60$11K
2026-07-24734$61.51$45K
2026-07-22361$60.93$22K
2026-07-212,346$60.16$141K
2026-07-2011,818$60.74$718K
2026-07-02965$56.44$54K
2026-06-302,336$58.56$137K
2026-06-25347,899$55.00$19.1M
2026-06-227,786$54.00$420K
2026-06-05545$56.60$31K
2026-06-0227,657$54.95$1.5M
2026-04-297,119$58.26$415K
2026-04-235,060$58.80$298K
2026-04-221,350$59.39$80K
2026-04-2016,428$60.17$988K
2026-04-1515$58.08$871
2026-04-1415,100$58.06$877K
2026-04-09170$59.20$10K
2026-04-08529$57.67$31K
2026-04-0217,500$61.73$1.1M
2026-03-251,467$57.39$84K
2026-03-0318,998$62.34$1.2M
2026-02-2730$61.10$2K
2026-02-261,118$61.30$69K
2026-02-2332,117$60.66$1.9M
2026-02-1833,995$60.35$2.1M
2026-02-1011,101$60.77$675K

Insider trades

SEC Form 4, newest first, 50 of 100 shown. JSON

Insiders at BMY reported 2 open-market sells worth $437K in the last 90 days and no open-market buys. Sells alone are a weak signal; insiders sell for tax, diversification and estate reasons all the time. Latest filing: Massacesi Cristian (EVP,Chief Med Offr,Head of Dev) on 2026-09-09.

DateInsiderTitleTypeSharesPriceValueOwned after
2026-09-09Massacesi CristianEVP,Chief Med Offr,Head of DevSell6K$64.57$403K19K
2026-09-01Short Bartie WendyEVP, Corporate AffairsTax withholding633$66.92$42K13K
2026-09-01Short Bartie WendyEVP, Corporate AffairsOption exercise1K$66.92$83K13K
2026-08-25Holzer Phil MSVP and ControllerSell500$67.50$34K17K
2026-08-01Massacesi CristianEVP,Chief Med Offr,Head of DevTax withholding26K$65.31$1.7M25K
2026-08-01Massacesi CristianEVP,Chief Med Offr,Head of DevOption exercise51K$0.00$051K
2026-08-01Gallman CariEVP, General CounselTax withholding543$65.31$35K14K
2026-08-01Gallman CariEVP, General CounselOption exercise1K$0.00$014K
2026-06-15Haller Julia An/aOption exercise20K$53.76$1.1M34K
2026-06-03Short Bartie WendyEVP, Corporate AffairsTax withholding4K$54.72$212K12K
2026-06-03Short Bartie WendyEVP, Corporate AffairsOption exercise8K$0.00$016K
2026-05-01Lenkowsky AdamEVP, Chief Commercial OfficerTax withholding599$58.22$35K20K
2026-05-01Lenkowsky AdamEVP, Chief Commercial OfficerJ203$0.00$020K
2026-05-01Lenkowsky AdamEVP, Chief Commercial OfficerOption exercise1K$0.00$021K
2026-04-01Shanahan KarinEVP, Chief Supply Chain &amp; OpsTax withholding2K$61.73$104K26K
2026-04-01Shanahan KarinEVP, Chief Supply Chain &amp; OpsOption exercise3K$0.00$028K
2026-04-01Elkins David VEVP, Chief Financial OfficerSell4K$62.05$278K159K
2026-04-01Elkins David VEVP, Chief Financial OfficerSell26K$61.60$1.6M164K
2026-03-10Short Bartie WendyEVP, Corporate AffairsTax withholding828$60.13$50K8K
2026-03-10Short Bartie WendyEVP, Corporate AffairsJ2K$0.00$09K
2026-03-10Short Bartie WendyEVP, Corporate AffairsOption exercise4K$0.00$011K
2026-03-10Short Bartie WendyEVP, Corporate AffairsTax withholding242$60.13$15K6K
2026-03-10Short Bartie WendyEVP, Corporate AffairsJ81$0.00$07K
2026-03-10Short Bartie WendyEVP, Corporate AffairsOption exercise749$0.00$07K
2026-03-10Short Bartie WendyEVP, Corporate AffairsTax withholding205$60.13$12K6K
2026-03-10Short Bartie WendyEVP, Corporate AffairsJ72$0.00$06K
2026-03-10Short Bartie WendyEVP, Corporate AffairsOption exercise639$0.00$06K
2026-03-10Holzer Phil MSVP and ControllerTax withholding849$60.13$51K17K
2026-03-10Holzer Phil MSVP and ControllerJ2K$0.00$018K
2026-03-10Holzer Phil MSVP and ControllerOption exercise5K$0.00$020K
2026-03-10Holzer Phil MSVP and ControllerTax withholding248$60.13$15K16K
2026-03-10Holzer Phil MSVP and ControllerJ83$0.00$016K
2026-03-10Holzer Phil MSVP and ControllerOption exercise768$0.00$016K
2026-03-10Holzer Phil MSVP and ControllerTax withholding261$60.13$16K15K
2026-03-10Holzer Phil MSVP and ControllerJ91$0.00$016K
2026-03-10Holzer Phil MSVP and ControllerOption exercise811$0.00$016K
2026-03-10Hoch LynellePresident, Cell Therapy Org.Tax withholding912$60.13$55K8K
2026-03-10Hoch LynellePresident, Cell Therapy Org.J3K$0.00$09K
2026-03-10Hoch LynellePresident, Cell Therapy Org.Option exercise6K$0.00$012K
2026-03-10Hoch LynellePresident, Cell Therapy Org.Tax withholding267$60.13$16K6K
2026-03-10Hoch LynellePresident, Cell Therapy Org.J113$0.00$06K
2026-03-10Hoch LynellePresident, Cell Therapy Org.Option exercise1K$0.00$06K
2026-03-10Hoch LynellePresident, Cell Therapy Org.Tax withholding212$60.13$13K5K
2026-03-10Hoch LynellePresident, Cell Therapy Org.J94$0.00$05K
2026-03-10Hoch LynellePresident, Cell Therapy Org.Option exercise838$0.00$06K
2026-03-10Poole Ahn AmandaEVP, Chief People OfficerTax withholding1K$60.13$76K7K
2026-03-10Poole Ahn AmandaEVP, Chief People OfficerJ2K$0.00$08K
2026-03-10Poole Ahn AmandaEVP, Chief People OfficerOption exercise5K$0.00$011K
2026-03-10Poole Ahn AmandaEVP, Chief People OfficerTax withholding367$60.13$22K6K
2026-03-10Poole Ahn AmandaEVP, Chief People OfficerJ87$0.00$06K

Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are the rarer, stronger signal.

Planned sales (Form 144)

Newest first. JSON

2 Form 144 notices on file for BMY worth $437K at the prices reported; 2 in the last 90 days worth $437K. Latest: Massacesi Cristian filed on 2026-09-09 to sell 6,249 shares ($403K) from 2026-09-09.

FiledSellerSharesMarket valueOf outstandingSale fromBroker
2026-09-09Massacesi CristianOfficer6K$403K0.000%2026-09-09Fidelity Brokerage Services LLC
2026-08-25Holzer Phil MOfficer500$34K0.000%2026-08-25Fidelity Brokerage Services LLC

Large holders (13D and 13G)

One row per reporting person, newest filing first. JSON

1 holder above 5% has filed on BMY, all on Schedule 13G (passive). The largest reported stake is STATE STREET CORPORATION at 5.0% of the class (102,521,748 shares), filed 2026-08-07 for an event on 2026-06-30.

FiledFormHolderSharesOf classEvent
2026-08-0713GSTATE STREET CORPORATIONparent holding company102.5M5.0%2026-06-30

13F holders

Tracked managers holding BMY at their latest 13F. JSON

7 of the 30 tracked managers held BMY at their latest 13F, $2.87B in total at quarter-end prices. AQR Capital Management is the largest at $1.58B (0.5% of its portfolio) as of 2026-06-30. Over the prior quarter 2 added shares and 5 cut.

FundQuarterSharesValueOf portfolioChange in shares
AQR Capital Management2026-06-3027.4M$1.58B0.55%-2.3M
Two Sigma Investments2026-06-3010.1M$581.5M0.42%-1.5M
Citadel Advisors2026-06-307.7M$442.9M0.05%-1.8M
D. E. Shaw & Co.2026-06-301.7M$97.0M0.05%+624K
Millennium Management2026-06-301.5M$86.4M0.03%-3.0M
Point72 Asset Management2026-06-301.4M$78.3M0.09%+259K
Fisher Asset Management2026-06-30173K$10.0M0.00%-30K

Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.

Financials

SEC XBRL, as filed. JSON

In Q2 2026 (quarter ended 2026-06-30) BRISTOL MYERS SQUIBB CO reported revenue of $12.97B, up 5.7% from the same quarter a year earlier, and net income of $3.32B (1.62 diluted EPS). In FY 2025 it generated $14.16B of operating cash flow and spent $5.04B on dividends. As of 2026-06-30, cash was $8.72B against $42.86B of debt.

Cash
$8.72B
Debt
$42.86B
Equity
$22.32B
Total assets
$87.63B
Shares outstanding
2,042,714,656

Quarterly, last 8 quarters

QuarterPeriod endRevenueNet incomeMarginDiluted EPS
Q2 20262026-06-30$12.97B$3.32B25.6%1.62
Q1 20262026-03-31$11.49B$2.68B23.3%1.31
Q4 2025derived2025-12-31$12.50B$1.09B8.7%n/a
Q3 20252025-09-30$12.22B$2.20B18.0%1.08
Q2 20252025-06-30$12.27B$1.31B10.7%0.64
Q1 20252025-03-31$11.20B$2.46B21.9%1.20
Q4 2024derived2024-12-31$12.34B$72.0M0.6%n/a
Q3 20242024-09-30$11.89B$1.21B10.2%0.60

Fiscal years, with buybacks and dividends

Fiscal yearEndsRevenueNet incomeOperating cash flowCapexBuybacksDividends
FY 20252025-12-31$48.19B$7.05B$14.16B$1.31B$0$5.04B
FY 20242024-12-31$48.30B-$8.95B$15.19B$1.25B$0$4.86B
FY 20232023-12-31$45.01B$8.03B$13.86B$1.21B$5.16B$4.74B
FY 20222022-12-31$46.16B$6.33B$13.07B$1.12B$8.00B$4.63B
FY 20212021-12-31$46.38B$6.99B$16.21B$973.0M$6.29B$4.40B

Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are cash paid to repurchase common stock in the year (XBRL PaymentsForRepurchaseOfCommonStock), not authorizations. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-07-22 from the cover page.

What this page is

BRISTOL MYERS SQUIBB CO in the regulatory record

Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page pulls every series the site collects for one ticker onto one URL, keyed by the SEC's own ticker list, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.

Each section has its own history table, a summary sentence built from the rows (last value, change, range with dates) and its own JSON and CSV links. Nothing on the page is written by a model; the sentences change only when the data does. A page exists only for companies with data in at least two series, and every section says when its source last updated.

This page follows BRISTOL MYERS SQUIBB CO (BMY), SEC CIK 14272, listed on NYSE, classified by the SEC as pharmaceutical preparations. The cross-market tables live on the short interest and insider transactions hubs.

Source and method

Short interest
FINRA consolidated short interestTwice a month, about eight business days after settlement. Latest 2026-08-14.JSON and CSV
Daily short volume
FINRA Reg SHO daily filesEvery trading day, loaded the following morning. Latest 2026-09-11.JSON and CSV
Fails to deliver
SEC fails-to-deliver dataTwice a month, a few weeks after the half month ends. Latest 2026-08-13.JSON and CSV
Planned sales
SEC EDGAR Form 144EDGAR read every 30 minutes; a notice is filed on or before the sell order. Latest 2026-09-09.JSON and CSV
Large holders
SEC EDGAR Schedule 13D and 13GEDGAR read every 30 minutes; 13D within five business days of crossing 5%, 13G on the passive schedule. Latest 2026-08-07.JSON and CSV
13F holders
SEC EDGAR Form 13F-HRQuarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
Financials
SEC XBRL company factsRefreshed weekly from the SEC's structured data; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
Insider trades
SEC EDGAR Form 4EDGAR read every 30 minutes; filings are due two business days after the trade. Latest 2026-09-09.JSON and CSV
Company record
EDGAR filing index for CIK 14272Ticker, name and exchange from the SEC's company list, refreshed weekly.
Rate limits
30 requests a minute without a key, 120 a minute with a key from a free account.

Data checks. Every dataset is checked against its source once a day. This dataset passed the last run, 13 Sep 05:40 UTC.

How to read it

  • Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
  • Insider buys next to a crowded short are the combination that has historically preceded squeezes; insider sells next to a crowded short are common and mean little.
  • Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.

Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.

Datasets

Frequently Asked Questions

How much of BMY is sold short?
45,852,662 shares were held short at the 2026-08-14 settlement, 3.5 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is BMY's daily short volume?
On 2026-09-11, 1,155,134 of the 2,229,246 BMY shares reported to FINRA were sold short, 51.8% of the day's reported volume. Short volume is a flow for one day, not a position.
Does BMY have fails to deliver?
The SEC's latest file shows 301 BMY shares failed to deliver at settlement 2026-08-13. Fails are reported per settlement date and published twice a month with a lag.
Are BMY insiders buying or selling?
Insiders at BMY reported 2 open-market sells worth $437K in the last 90 days and no open-market buys. Sells alone are a weak signal; insiders sell for tax, diversification and estate reasons all the time. Latest filing: Massacesi Cristian (EVP,Chief Med Offr,Head of Dev) on 2026-09-09.
Have BMY insiders filed to sell?
2 Form 144 notices on file for BMY worth $437K at the prices reported; 2 in the last 90 days worth $437K. Latest: Massacesi Cristian filed on 2026-09-09 to sell 6,249 shares ($403K) from 2026-09-09.
Who owns more than 5% of BMY?
1 holder above 5% has filed on BMY, all on Schedule 13G (passive). The largest reported stake is STATE STREET CORPORATION at 5.0% of the class (102,521,748 shares), filed 2026-08-07 for an event on 2026-06-30.
What did BMY report last quarter?
In Q2 2026 (quarter ended 2026-06-30) BRISTOL MYERS SQUIBB CO reported revenue of $12.97B, up 5.7% from the same quarter a year earlier, and net income of $3.32B (1.62 diluted EPS). In FY 2025 it generated $14.16B of operating cash flow and spent $5.04B on dividends. As of 2026-06-30, cash was $8.72B against $42.86B of debt.
Which funds hold BMY?
7 of the 30 tracked managers held BMY at their latest 13F, $2.87B in total at quarter-end prices. AQR Capital Management is the largest at $1.58B (0.5% of its portfolio) as of 2026-06-30. Over the prior quarter 2 added shares and 5 cut.

Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.